dha suicide care pathway Flashcards

What's on the cards

1. Who must receive training on the suicide risk care processes and procedures?
2. Which tool standardizes suicide risk level determination in the pathway?
3. Which acute suicide risk levels require a safety plan?
4. What tracking mechanisms must providers implement for at-risk patients?
5. How should providers incorporate individual patient needs when following the pathway?
6. Does suicidal ideation alone necessarily indicate imminent risk or require a warm hand-off?
7. When BH or PCBH resources are unavailable for a patient with suicide warning signs, what transfer and observation actions are required?
8. Which forms of communicating suicidal intent are listed as suicide warning signs?
9. What behavior involving lethal means is listed as a warning sign when paired with suicidal ideation?
10. What preparatory behavior is given as an example of a warning sign when paired with suicidal ideation?
11. Is telemedicine permitted for suicide risk care?
12. Outside BH specialty care, which C-SSRS version should providers use when suicide risk screening is clinically indicated?
13. Which past-month C-SSRS items should be completed for all patients?
14. What constitutes a negative C-SSRS screen, and is follow-up required for that negative screen?
15. What should a provider do when a patient answers yes to C-SSRS Items 1, 2, and/or 7 only?
16. Which affirmative C-SSRS responses make the past-month screen positive?
17. What clinical follow-up and referral are indicated after a positive suicide risk screen?
18. What hand-off is required when a patient's safety concerns require immediate management?
19. Which suicide screening tool must BH providers use at initial intake encounters in BH specialty settings?
20. Which C-SSRS version is specified for follow-up, non-intake BH encounters?
21. Which items should be completed for every patient receiving the follow-up C-SSRS screener?
22. May a BH provider determine suicide risk level solely from C-SSRS screener responses?
23. What risk level must BH providers assign when a patient has safety concerns requiring immediate management?
24. What is the standard documentation deadline for the current suicide risk level and its clinical basis following comprehensive assessment?
25. What copy of the safety plan must the patient have when the clinical encounter ends?
26. Which safety-plan component addresses safe firearm storage and disposal of excess medications?
27. An intermediate- or high-acute-risk patient misses an appointment without prior communication. When must the provider call, and what should the call address?
28. What three components must a standard inpatient BH discharge plan include for a patient with suicide risk?
29. How soon after inpatient BH discharge must outpatient or partial hospitalization follow-up be planned?
30. Discharge from psychiatric or BH hospitalization or residential treatment within what period requires placement on the at-risk tracking list?
31. A suicide attempt within what look-back period is a criterion for considering placement on the at-risk tracking list?
32. What firearm-storage practices are listed as ways to reduce access to lethal means?
33. Who must establish procedures for reporting mandated suicide events among active duty Service members, and which system is used?
34. When must BH providers at MTFs complete the required suicide risk care training, and how often must they repeat it?
35. What suicide risk care training must health care providers other than BH providers at MTFs complete, and where is it accessed?
36. How does DHA-AI 6025.06 define preparatory behaviors?
37. What defines a suicide attempt under DHA-AI 6025.06?
38. When selecting a suicide risk screening tool, what type of measure does the CPG suggest?
39. Which three screening tools does the CPG list for the general population?
40. Does the CPG recommend a specific tool or method for determining a patient's level of suicide risk?
41. What psychotherapy does the CPG suggest to reduce suicide attempts in patients with suicidal behavior within the past six months?
42. What psychotherapy does the CPG suggest to reduce suicidal ideation in patients with a history of self-directed violence?
43. Which medication does the CPG suggest to reduce suicide attempts in patients with schizophrenia or schizoaffective disorder and suicidal ideation or previous suicide attempts?
44. What adjunctive treatment does the CPG suggest for short-term reduction of suicidal ideation in patients with major depressive disorder?
45. Does the CPG recommend ketamine infusions or esketamine to reduce suicide or suicide attempts?
46. What is the CPG recommendation on lithium for reducing suicide or suicide attempts in patients with mood disorders?
47. For how long after hospitalization related to suicide risk does the CPG suggest periodic caring communications, and how should they relate to usual care?
48. What type of self-guided digital intervention does the CPG suggest for short-term reduction in suicidal ideation?
49. What access-related intervention does the CPG suggest to reduce suicide by firearms, jumping, or medication overdose?
50. What examples of preparation for suicide and lethal-means-related warning signs appear in the pocket guide?
51. Which protective factors should a clinician consider during a suicide risk assessment according to the pocket guide?
52. What two core features characterize high acute suicide risk in the pocket guide?
53. What distinguishes intermediate acute suicide risk from a similar presentation at high acute risk in the pocket guide?
54. During direct observation of a patient at high acute suicide risk, what environmental restriction does the pocket guide specify?
55. What four components should enhanced care management include according to the pocket guide?
56. What term describes another person's suicidal act influencing someone to consider or attempt suicide?
57. Who is the intended recipient of a postvention activity?
58. For which events must designated trained personnel complete a DoDSER entry?
59. What accuracy and submission requirements apply to DoDSER inputs overseen by the Chief, PHCoE?
60. At which stages must Military Departments provide suicide prevention training to uniformed behavioral health professionals?
61. What type of suicide prevention and clinical intervention programs must the Director, DHA integrate across the Military Health System?
62. What must the Director, DHA ensure is readily available to providers alongside distribution of the suicide risk clinical practice guideline?
63. According to the VA/DoD provider guide, in which two situations should lethal means counseling be used?
64. What home-storage information should a clinician assess when raising lethal means safety?
65. What should follow-up confirm after a lethal means safety plan is developed?
66. How should firearms be stored under the routine safe-storage recommendations?
67. What medication quantity and pharmacy guidance should a clinician recommend for lethal means safety?
68. What reassurance should accompany recommendations to temporarily restrict firearm access?
69. Which categories of firearm access should be assessed during suicide risk assessment and safety planning?

Answers are on the backs of the cards — or open the full dha suicide care pathway answer key to read them all at once.